Yuji Otsuki is the CEO of FerroptoCure which is developing the ferroptosis inducing anti-cancer therapy. He was a thoracic surgeon and he has experienced to treat many cancer patients with poor prognosis. However, he has become a researcher of cancer biology because he was shocked that the current treatments were not able to cure the patients with refractory cancers. He has started to research since 2016 and could achieved the findings on which can be the new anti-cancer therapy. Therefore, he has established FerroptoCure based on those achievements.